Literature DB >> 11552786

Percutaneous implantation of subcutaneous prosthetic ureters: long-term outcome.

M E Jabbour1, F Desgrandchamps, E Angelescu, P Teillac, A Le Duc.   

Abstract

PURPOSE: We have used an extra-anatomic subcutaneous alloplastic ureteral replacement initially to bypass ureteral obstruction secondary to advanced pelvic malignancies in patients with a short life expectancy. Following the encouraging preliminary results, our list of indications has broadened to include complex benign ureteral strictures. We herein report the long-term outcome. PATIENTS AND METHODS: A series of 35 subcutaneous prosthetic ureters were implanted percutaneously in 27 patients (19 unilateral and 8 bilateral) to bypass extrinsic ureteral obstructions. The nature of obstruction was neoplastic in 22 patients and benign in 5. A composite prosthesis, consisting of two coaxial tubes--internal pure smooth silicone covered by coiled e-PTFE--has been designed to serve as the ureteral replacement. This tube is inserted percutaneously into the renal pelvis, tunnelled subcutaneously, and introduced through a small suprapubic incision in the bladder. All patients were followed to date or until death from tumor. The mean follow-up was 6.3 months for the deceased patients and 47 months for the surviving ones, the longest follow-up being 84 months.
RESULTS: No operative or immediate postoperative deaths were observed. Initial difficulty in placing the prosthesis was encountered in 5 of the 27 patients (19%). Secondary parietal complications occurred in 8.5% of cases (3/35). The prosthetic ureter had to be removed in one patient because of skin erosion. Return to a standard percutaneous nephrostomy was needed in two patients because of local tumor progression with bladder fistulae. Five patients are alive with the prosthesis in place and a follow-up as long as 84 months without encrustation, infection, obstruction, or skin problems and with normally functioning kidneys.
CONCLUSION: The subcutaneous urinary diversion using a silicone-PTFE prosthesis is an efficient and minimally invasive way to bypass malignant or complex benign obstructions of the ureters that otherwise would necessitate permanent nephrostomy drainage.

Entities:  

Mesh:

Year:  2001        PMID: 11552786     DOI: 10.1089/089277901750426391

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  9 in total

1.  [Prosthetic pyelovesical and pyelocutanous bypass. A palliative therapy concept in tumor-induced chronic hydronephprosis].

Authors:  H Loertzer; A Jurczok; S Wagner; P Fornara
Journal:  Urologe A       Date:  2003-05-27       Impact factor: 0.639

2.  Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis.

Authors:  Nicholas Haddad; Sero Andonian; Maurice Anidjar
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

Review 3.  Current status of minimally invasive endoscopic management of ureteric strictures.

Authors:  Stefanos Kachrilas; Andreas Bourdoumis; Theocharis Karaolides; Stavroula Nikitopoulou; George Papadopoulos; Noor Buchholz; Junaid Masood
Journal:  Ther Adv Urol       Date:  2013-12

Review 4.  [Treatment of specific complications of locally advanced prostate cancer].

Authors:  F C von Rundstedt; A S Brandt; D Lazica; M J Mathers; S Roth
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

5.  Long-term results of the treatment of complex ureteral stenosis with extra-anatomic ureteral bypasses.

Authors:  Inés M Laso-García; Javier Lorca-Álvaro; Fernando Arias-Fúnez; David Díaz-Pérez; Marta Santiago-González; Gemma Duque-Ruiz; Francisco J Burgos-Revilla
Journal:  Cent European J Urol       Date:  2020-06-19

6.  [Long-term results for subcutaneous Detour® prosthesis for ureteral obstruction: experiences of implantation, aftercare and management of complications].

Authors:  A Janitzky; J Borski; M Porsch; J J Wendler; D Baumunk; U-B Liehr; M Schostak
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

7.  [Retroperitoneal fibrosis].

Authors:  S Burkhardt Soares; S Kukuk; A S Brandt; A Fehr; S Roth
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

8.  Subcutaneous nephrovesical bypass: Treatment for ureteral obstruction in advanced metastatic disease.

Authors:  Yunyan Wang; Gongcheng Wang; Peijin Hou; Haijun Zhuang; Xiaosong Yang; Shuo Gu; Hengbing Wang; Lu Ji; Zongyuan Xu; Junsong Meng
Journal:  Oncol Lett       Date:  2014-11-06       Impact factor: 2.967

9.  Subcutaneous nephrovesical bypass in kidney transplanted patients.

Authors:  M Yazdani; M R Gharaati; M Zargham
Journal:  Int J Organ Transplant Med       Date:  2010
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.